Thymogen

No completed human trials extracted for Thymogen. Animal-model evidence carries the indication cards below.

Data last updated

ClinicalResearchDepthClinicalResearchEfficacyno dataClinicalResearchSideEffectsno dataAnecdotalEfficacyAnecdotalSideEffectsno dataPrice0.43.02.0

Measured on 3 of 6 axes

Research Evidence

Evidence shape

Thymogen currently lacks human clinical evidence, as all existing research is restricted to animal models and preclinical mechanistic studies. There are no registered human trials, and the literature does not support any specific therapeutic indications in clinical populations. Because the peptide has not progressed beyond basic laboratory research, there is no data regarding human safety, efficacy, or optimal dosing protocols.

Depthhow much
0 registered trials
Breadthhow many areas
1 indication mapped
1 animal-only
Qualityhow rigorous
No completed trials
Breadth and depth12 rows captured
Human
direct clinical signal
0
Animal
translational support
10
In vitro
mechanistic support
2
HighMediumLow

Anecdotal efficacy

Thymogen side effects

Clinical research side effects

Clinical safety table not projected yet.

Anecdotal side effects

Symptom-relevant clinical or community evidence has not been captured for this peptide yet.

Price

Full buying guide →
1
Rp Peptides
GB
20 mg
$36.24
$1.81/mg
2
Aminousa
US
20 mg
$45.00
$2.25/mg
3
PureHealth Peptides
--
20 mg
$49.00
$2.45/mg
4
Mile High Compounds
USA
20 mg
$49.99
$2.5/mg
5
PureLab Peptides
USA
20 mg
$69.99
$3.5/mg
6
Huaian Hanyou Peptide
China
20 mg
$73.00
$3.65/mg

price offers can be sorted by column · 1 out-of-stock offer not shown

1-6 of 13

Thymogen dosing & protocol

How Thymogen is dosed across research, clinician, and community sources — each evidence tier kept separate so the dose range, frequency, timing, and cycling stay visible without flattening different levels of evidence.

Research trials
Published clinical-trial protocols
Typical dose
—
0
1 mg
2 mg
3 mg
4 mg
5 mg
no dose captured for this tier yet

No structured protocol details captured for this tier yet.

Clinician practice
Doctor & published-protocol guidance
Typical dose
—
0
1 mg
2 mg
3 mg
4 mg
5 mg
no dose captured for this tier yet

No structured protocol details captured for this tier yet.

Anecdotal
Community-reported real-world use · n = 1
Typical dose
2 mg2 mg – 5 mg
typical
0
1 mg
2 mg
3 mg
4 mg
5 mg
distribution of 2 reported doses · darker = more
Frequency
unspecified
Route
subQ

One community source reports a typical dose of 2 mg, with a range of 2–5 mg, given subcutaneously. Frequency and cycling were not specified in the report.

1 source

Related peptides

PinealonCortagenBronchogenCrystagenPancragenCardiogenCartalaxLivagenTestagenVilonOvagenChonluten